FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207520621> ?p ?o ?g. }

• W3207520621 endingPage "S59" @default.
• W3207520621 startingPage "S58" @default.
• W3207520621 abstract "Stimulants are prescribed to children and adolescents around the world for ADHD. Clinicians are understandably concerned because stimulants can also be a substance of abuse. We seek to compare and contrast stimulant use and abuse between the United States and Thailand, as well as look at how proper stimulant use effects future rates of stimulant abuse. Data regarding stimulant medications and prescription data from the United States and Thailand will be presented. Epidemiological data on stimulant use disorder in adolescents and young adults will be compared in the United States and in Thailand. While there are various stimulant options for ADHD treatment available in the United States, for the past several years in Thailand, there has been only 1 stimulant medication for ADHD available: methylphenidate. Although there is no clear reason for this limited availability of stimulant medication in Thailand, the following factors may play a role: public perception regarding stimulants, strict regulation by the Thai FDA, cultural background pertaining to the doctor-patient relationship, and differences in the investment priorities of pharmaceutical companies. Stimulant use disorder continues to grow globally in the young population. A survey study of adolescent students in Thailand indicates that among the top 3 substances abused are the amphetamine derivatives: Yaba (a mixture of methamphetamine and caffeine) and crystal methamphetamine. Yaba is also the leading cause for seeking substance use treatment in adolescents aged 15 years and under in Thailand. However, there are some limitations and challenges when comparing the epidemiological data of stimulant use disorders between countries in different regions due to the availability and popularity of each drug and differences in research methodology. There is already well-documented evidence that untreated ADHD is a risk factor for substance use disorder in the future, and stimulant treatment for ADHD is one of the protective factors against future substance use disorder in populations with ADHD. Stimulant use disorder is a growing problem globally. From the available data, the fact that there is only 1 stimulant medication in use in Thailand does not appear to limit the prevalence of stimulant use disorder." @default.
• W3207520621 created "2021-10-25" @default.
• W3207520621 creator A5066594035 @default.
• W3207520621 date "2021-10-01" @default.
• W3207520621 modified "2023-09-27" @default.
• W3207520621 title "40.1 THE USE AND ABUSE OF STIMULANTS IN CHILDREN AND ADOLESCENTS IN THE UNITED STATES AND THAILAND" @default.
• W3207520621 doi "https://doi.org/10.1016/j.jaac.2021.07.251" @default.
• W3207520621 hasPublicationYear "2021" @default.
• W3207520621 type Work @default.
• W3207520621 sameAs 3207520621 @default.
• W3207520621 citedByCount "0" @default.
• W3207520621 crossrefType "journal-article" @default.
• W3207520621 hasAuthorship W3207520621A5066594035 @default.
• W3207520621 hasConcept C118552586 @default.
• W3207520621 hasConcept C15744967 @default.
• W3207520621 hasConcept C2426938 @default.
• W3207520621 hasConcept C2777112843 @default.
• W3207520621 hasConcept C2780376393 @default.
• W3207520621 hasConcept C2780557958 @default.
• W3207520621 hasConcept C2780783007 @default.
• W3207520621 hasConcept C2908647359 @default.
• W3207520621 hasConcept C40010229 @default.
• W3207520621 hasConcept C71924100 @default.
• W3207520621 hasConcept C98274493 @default.
• W3207520621 hasConcept C99454951 @default.
• W3207520621 hasConceptScore W3207520621C118552586 @default.
• W3207520621 hasConceptScore W3207520621C15744967 @default.
• W3207520621 hasConceptScore W3207520621C2426938 @default.
• W3207520621 hasConceptScore W3207520621C2777112843 @default.
• W3207520621 hasConceptScore W3207520621C2780376393 @default.
• W3207520621 hasConceptScore W3207520621C2780557958 @default.
• W3207520621 hasConceptScore W3207520621C2780783007 @default.
• W3207520621 hasConceptScore W3207520621C2908647359 @default.
• W3207520621 hasConceptScore W3207520621C40010229 @default.
• W3207520621 hasConceptScore W3207520621C71924100 @default.
• W3207520621 hasConceptScore W3207520621C98274493 @default.
• W3207520621 hasConceptScore W3207520621C99454951 @default.
• W3207520621 hasIssue "10" @default.
• W3207520621 hasLocation W32075206211 @default.
• W3207520621 hasOpenAccess W3207520621 @default.
• W3207520621 hasPrimaryLocation W32075206211 @default.
• W3207520621 hasRelatedWork W1673405199 @default.
• W3207520621 hasRelatedWork W1975343712 @default.
• W3207520621 hasRelatedWork W2043552268 @default.
• W3207520621 hasRelatedWork W2118374778 @default.
• W3207520621 hasRelatedWork W2127950365 @default.
• W3207520621 hasRelatedWork W2159901703 @default.
• W3207520621 hasRelatedWork W4283756087 @default.
• W3207520621 hasRelatedWork W645179416 @default.
• W3207520621 hasRelatedWork W67021727 @default.
• W3207520621 hasRelatedWork W2126205803 @default.
• W3207520621 hasVolume "60" @default.
• W3207520621 isParatext "false" @default.
• W3207520621 isRetracted "false" @default.
• W3207520621 magId "3207520621" @default.
• W3207520621 workType "article" @default.